Pietr R. Cullis
Affiliations: | University of British Columbia, Vancouver, Vancouver, BC, Canada |
Area:
General BiophysicsGoogle:
"Pietr Cullis"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Kulkarni JA, Witzigmann D, Leung J, et al. (2019) On the role of helper lipids in lipid nanoparticle formulations of siRNA. Nanoscale |
Zhang W, Böttger R, Qin Z, et al. (2019) Phospholipid-Free Small Unilamellar Vesicles for Drug Targeting to Cells in the Liver. Small (Weinheim An Der Bergstrasse, Germany). e1901782 |
Kulkarni JA, Witzigmann D, Chen S, et al. (2019) Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics. Accounts of Chemical Research |
Ramezanpour M, Schmidt ML, Bodnariuc I, et al. (2019) Ionizable amino lipid interactions with POPC: implications for lipid nanoparticle function. Nanoscale |
Jyotsana N, Sharma A, Chaturvedi A, et al. (2019) Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo. Annals of Hematology |
Kulkarni JA, Witzigmann D, Leung J, et al. (2019) Fusion-dependent formation of lipid nanoparticles containing macromolecular payloads. Nanoscale |
Buck J, Grossen P, Cullis PR, et al. (2019) Lipid-Based DNA Therapeutics: Hallmarks of Non-Viral Gene Delivery. Acs Nano |
Maclachlan I, Cullis P. (2019) "Diffusible-PEG-Lipid Stabilized Plasmid Lipid Particles" Advances in Genetics. 157-188 |
Kulkarni JA, Cullis PR, van der Meel R. (2018) Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility. Nucleic Acid Therapeutics |
Kulkarni JA, Darjuan MM, Mercer JE, et al. (2018) On the Formation and Morphology of Lipid Nanoparticles Containing Ionizable Cationic Lipids and siRNA. Acs Nano |